HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Om Silakari Selected Research

dimethylethylsilylimidazole

1/2021Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review.
1/2019Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Om Silakari Research Topics

Disease

22Neoplasms (Cancer)
10/2022 - 04/2014
9Diabetes Complications
01/2021 - 05/2014
9Inflammation (Inflammations)
12/2018 - 09/2013
6Rheumatoid Arthritis
12/2018 - 05/2010
5Alzheimer Disease (Alzheimer's Disease)
01/2018 - 01/2013
4Asthma (Bronchial Asthma)
12/2018 - 01/2012
4Lung Neoplasms (Lung Cancer)
10/2018 - 01/2016
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2021 - 11/2016
3Psoriasis (Pustulosis Palmaris et Plantaris)
12/2018 - 09/2013
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2018 - 01/2012
2Diabetic Neuropathies (Diabetic Neuropathy)
01/2022 - 01/2021
2Hypertension (High Blood Pressure)
05/2021 - 07/2017
2Malaria
05/2021 - 08/2014
2Hyperglycemia
01/2021 - 01/2020
2COVID-19
01/2021 - 11/2020
2Cardiotoxicity
06/2020 - 07/2018
2Tuberculosis (Tuberculoses)
01/2019 - 12/2018
2Vomiting
07/2018 - 07/2017
2Pain (Aches)
07/2015 - 01/2013
2Cardiovascular Diseases (Cardiovascular Disease)
09/2014 - 08/2014
2Autoimmune Diseases (Autoimmune Disease)
09/2013 - 02/2013
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Cognitive Dysfunction
01/2021
1Triple Negative Breast Neoplasms
01/2021
1Nervous System Diseases (Neurological Disorders)
01/2021
1Stroke (Strokes)
06/2020
1Myocardial Infarction
06/2020
1Ulcerative Colitis
12/2018
1Crohn Disease (Crohn's Disease)
12/2018
1Atherosclerosis
12/2018
1Drug-Related Side Effects and Adverse Reactions
05/2018

Drug/Important Bio-Agent (IBA)

10Pharmaceutical PreparationsIBA
09/2022 - 08/2014
8EnzymesIBA
09/2022 - 02/2013
8Biological ProductsIBA
01/2021 - 01/2012
7Aldehyde Reductase (Aldose Reductase)IBA
01/2022 - 06/2015
5AntioxidantsIBA
01/2021 - 09/2014
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2022 - 10/2020
4Phosphotransferases (Kinase)IBA
10/2018 - 09/2013
3Proteins (Proteins, Gene)FDA Link
10/2022 - 07/2015
3CytokinesIBA
01/2021 - 06/2015
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2020 - 11/2014
3LigandsIBA
10/2018 - 01/2014
2epalrestatIBA
01/2022 - 01/2021
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2021 - 11/2016
2dimethylethylsilylimidazoleIBA
01/2021 - 01/2019
2Amino AcidsFDA Link
01/2021 - 07/2017
2Cholinesterases (Cholinesterase)IBA
01/2021 - 09/2014
2Glutathione (Reduced Glutathione)IBA
01/2021 - 06/2014
2FlavonesIBA
01/2020 - 09/2014
2polyolIBA
01/2020 - 12/2018
2thiazolidine-2,4-dioneIBA
01/2017 - 07/2015
2Protein Kinases (Protein Kinase)IBA
01/2017 - 09/2014
1Cytochrome P-450 CYP1B1IBA
10/2022
1Aldehyde Dehydrogenase 1 FamilyIBA
09/2022
1aldophosphamideIBA
09/2022
1Oxidoreductases (Dehydrogenase)IBA
09/2022
1carboxyphosphamideIBA
09/2022
1phosphoramide mustardIBA
09/2022
1Alkylating AgentsIBA
09/2021
1Imatinib Mesylate (Gleevec)FDA Link
08/2021
1Vitamin DFDA LinkGeneric
08/2021
1BenzimidazolesIBA
05/2021
1Biomarkers (Surrogate Marker)IBA
05/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1CatalaseIBA
01/2021
1quinone (benzoquinone)IBA
01/2021
1Cholinergic Agents (Cholinergics)IBA
01/2021
1Protective AgentsIBA
01/2021
1Protein Isoforms (Isoforms)IBA
01/2021
1Histone MethyltransferasesIBA
01/2021
1TamoxifenFDA LinkGeneric
01/2021
1Histones (Histone)IBA
01/2021
1Janus Kinase InhibitorsIBA
01/2021
1Immunologic Factors (Immunomodulators)IBA
01/2021
1methyl ferulateIBA
01/2021
1ProdrugsIBA
01/2021
1Lysine (L-Lysine)FDA Link
01/2021
1Thiobarbituric Acid Reactive SubstancesIBA
01/2021
1umifenovirIBA
11/2020
1Peptide Hydrolases (Proteases)FDA Link
11/2020
1DNA (Deoxyribonucleic Acid)IBA
10/2020
1Therapeutic UsesIBA
10/2020
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
06/2020
1L-Iditol 2-Dehydrogenase (L Iditol 2 Dehydrogenase)IBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1ErbB Receptors (EGF Receptor)IBA
07/2019
1Proto-Oncogene Proteins c-metIBA
07/2019
1PolymersIBA
01/2019
1DNA GyraseIBA
01/2019
1Blood Glucose (Blood Sugar)IBA
01/2019
1Drug CombinationsIBA
12/2018
1benzoxazoloneIBA
12/2018
1Advanced Glycation End ProductsIBA
12/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2018
1FluoroquinolonesIBA
12/2018
1ZincIBA
10/2018
1polycystic kidney disease 1 proteinIBA
02/2018

Therapy/Procedure

13Therapeutics
09/2021 - 05/2010
3Drug Therapy (Chemotherapy)
01/2019 - 06/2014